HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION

HPGC Renmintongtai Pharmaceutical Corporation

600829

CNE000000G05

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-26 EDT			5-day change	1st Jan Change
6.54 ^CNY	+0.46%		-3.25%	-16.37%

04-19	HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-27	HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

HPGC Renmintongtai Pharmaceutical Corporation announced that it expects to receive funding from Harbin Pharmaceutical Group Co., Ltd.

April 29, 2019

HPGC Renmintongtai Pharmaceutical Corporation (SHSE:600829) announced that it will receive an equity round of funding from returning investor Harbin Pharmaceutical Group Co., Ltd. (SHSE:600664) on April 30, 2019.

Latest news about HPGC Renmintongtai Pharmaceutical Corporation

HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	04-19	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
HPGC Renmintongtai Chairman Steps Down; Successor Named	12-18	MT
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-11	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-12	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-20	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-15	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-06	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-19	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-19	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-16	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-14	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-17	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-10	CI
HPGC Renmintongtai Pharmaceutical Corporation Approves Amending of Articles of Association	19-12-11	CI
HPGC Renmintongtai Pharmaceutical Corporation announced that it has received funding from Harbin Pharmaceutical Group Co., Ltd.	19-12-08	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-18	CI
Harbin Pharmaceutical Group Holding Co., Ltd. made an offer to acquire minority stake in HPGC Renmintongtai Pharmaceutical Corporation for CNY 0.02 million.	19-09-24	CI
Harbin Pharmaceutical Group Holding Co., Ltd. made an offer to acquire 25.2% stake in HPGC Renmintongtai Pharmaceutical Corporation for approximately CNY 970 million.	19-08-22	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-16	CI
HPGC Renmintongtai Pharmaceutical Corporation announced that it expects to receive funding from Harbin Pharmaceutical Group Co., Ltd.	19-04-29	CI

Chart HPGC Renmintongtai Pharmaceutical Corporation

Duration

Period

Chart HPGC Renmintongtai Pharmaceutical Corporation

More charts

Company Profile

HPGC Renmintongtai Pharmaceutical Corporation, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd., is a China-based company, principally engaged in the wholesale and retail of pharmaceuticals. The Company principally engages in the sales of Chinese medicines and western drugs. It also engages in the sales of medical equipment, healthcare products, daily necessities, glass apparatus, chemical, among others. The Company distributes its products mainly within domestic markets.

Sector

Pharmaceuticals

Calendar

2024-06-06 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION	-16.37%	521M
MCKESSON CORPORATION	+21.11%	72.89B
CARDINAL HEALTH, INC.	-4.38%	23.48B
SINOPHARM GROUP CO. LTD.	+6.11%	8.51B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+10.16%	8.42B
HUADONG MEDICINE CO., LTD	-22.99%	7.56B
H. LUNDBECK A/S	+12.88%	5.22B
EBOS GROUP LIMITED	+0.14%	4.2B
GALENICA AG	+0.48%	3.91B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+10.84%	3.91B